Trial intelligence / Profile preview

Bu/Cy Conditioning for Cord Blood Transplant

NCT01339988Phase 4Unknown

Sponsor
Tel Aviv Sourasky Medical Center
Start
Jun 2011
Primary completion
Jun 2014
Modality
Small Molecules
01

Overview

A Phase 4 trial of busulfan in acute leukemia, B-cell chronic lymphocytic leukemia (B-CLL), myelodysplastic syndrome (MDS), juvenile myelomonocytic leukemia (JMML), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.

02

Drugs

busulfan
03

Conditions

acute leukemiaB-cell chronic lymphocytic leukemia (B-CLL)myelodysplastic syndrome (MDS)juvenile myelomonocytic leukemia (JMML)

Beyond the preview

Go deeper on NCT01339988.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01339988.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call